Topics

As $SRPT awaits approval of new Duchenne drug, big questions hang over therapy already on market https://www.statnews.com/2019/08/15/sarepta-duchenne-drug-questions-exondys-51/ … I wrote about Exondys 51 and the promised (required) confirmatory trial

07:45 EDT 15 Aug 2019 | STAT

As awaits approval of new Duchenne drug, big questions hang over therapy already on market https://www.statnews.com/2019/08/15/sarepta-duchenne-drug-questions-exondys-51/ … I wrote about Exondys 51 and the promised (required) confirmatory trial that is 3-4 yrs behind schedule.

Original Article: As $SRPT awaits approval of new Duchenne drug, big questions hang over therapy already on market https://www.statnews.com/2019/08/15/sarepta-duchenne-drug-questions-exondys-51/ … I wrote about Exondys 51 and the promised (required) confirmatory trial

NEXT ARTICLE

More From BioPortfolio on "As $SRPT awaits approval of new Duchenne drug, big questions hang over therapy already on market https://www.statnews.com/2019/08/15/sarepta-duchenne-drug-questions-exondys-51/ … I wrote about Exondys 51 and the promised (required) confirmatory trial "

Quick Search

Relevant Topic

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...